QIAGEN powered by

Rapid, evidence-based reporting of oncology NGS tests at scale – Dec. 3

Date: 2021/12/03 Duration: 01:00:00 Presented by: Beate Litzenburger, Ph.D. Global Product Director of Oncology QIAGEN Digital Insights and Sheryl Elkin, PhD Chief Scientific Officer N-of-One, a QIAGEN company

Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.

In this webinar, attendees will learn:

  • How QCI Interpret One computes variant classifications
  • How simple it is to submit variants for professional interpretation via the software
  • How QCI Interpret One eliminates the need for variant curation
  • How users can generate customizable, oncologist-ready reports according to AMP/ASCO/CAP guidelines for therapeutic, prognostic, and diagnostic actionability

Click here to register.